Subversion of the chemokine world by microbial pathogens

BioEssays

Volumn 25, Issue 5, 2003, Pages 478-488

  Liston, Adrian ^a   McColl, Shaun ^b  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GLYCOSAMINOGLYCAN; INTERLEUKIN 11 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENETICS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VIRUS PATHOGENESIS;

ANIMALS; BACTERIA; CHEMOKINES; CHEMOTAXIS; GLYCOSAMINOGLYCANS; HUMANS; LEUKOCYTES; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUSES;

MAMMALIA;

EID: 0038218002     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10273     Document Type: Review

References (84)

1. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 1997;61:136-169.
2. Haig DM. Subversion and piracy: DNA viruses and immune evasion. Res Vet Sci 2001;70:205-219.
3. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. 2000; 21:447-455.
4. Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001;2:95-101.
5. Baggiorini M. Chemokines and leukocyte traffic. Nature 1998;392:565-568.
6. Koopmann W, Ediriwickrema C, Krangel MS. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta. J Immunol 1999;163:2120-2127.
7. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675-705.
8. Gale LM, McColl SR. Chemokines: extracellular messengers for all occasions? Bioessays 1999;21:17-28.
9. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 1998;188:855-866.
10. Liu L, Lalani A, Dai E, Seet B, Macauley C, Singh R, Fan L, McFadden G, Lucas A. The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest 2000;105: 1613-1621.
11. Albini A, et al. HIV-1 Tat protein mimicry of chemokines. Proc Nat Acad Sci USA 1998;95:13153-13158.
12. Rao SP, Hayashi T, Catanzaro A. Identification of a chemotactic, MCP-1-like protein from Mycobacterium avium. FEMS Immun Med Microbiol 2002;33:115-124.
13. Crump MP, Elisseeva E, Gong JH, Clark-Lewis I, Sykes BD. Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10). FEBS Letters 2001;489:171-175.
14. Parcells MS, et al. Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J Virol 75 2001;11:5159-5173.
15. Penfold MET, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ. Cytomegalovirus encodes a potent alpha chemokine. Proc Nat Acad Sci USA 1999;96:9839-9844.
16. Mahalingam S, Clark K, Matthaei KI, Foster PS. Antiviral potential of chemokines. Bioessays 2001;23:428-435.
17. Schultz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 1998;79:1573-1591.
18. Lüttichau HR, Clark-Lewis I, Gerstoft J, Schwartz TW. The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur J Immunol 2001;31:1217-1220.
19. Billstrom MA, Johnson GL, Avdi NJ, Worthen GS. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J Virol 1998;72:5535-5544.
20. Gershengorn MC, Geras-Raaka E, Varma A, Clark-Lewis I. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 1998;102:1469-1472.
21. Bais C, et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86-89.
22. Horst PJ, Rosenkilde MM, Manfra D, Chen S, Wiekowshi MT, Holst B, Cifire F, Lipp M, Schwartz TW, Lira SA. Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J Clin Invest 2001;108:1789-1796.
23. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997;385: 347-350.
24. Casarosa P, Bakker RA, Verzijl D, Navis M, Timmerman H, Leurs R, Smit MJ. Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J Biol Chem 2001;276:1133-1137.
25. Kirshner JR, Staskus K, Haase A, Lagunoff M, Ganem D. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J Virol 1999;73:6006-6014.
26. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996; 70:8218-8223.
27. Geras-Raaka E, Varma A, Ho H, Clark-Lewis I, Gershengorn MC. Human Interferon-inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi's Sarcoma-associated Herpesvirus. J Exp Med 1998;188:405-408.
28. Meissner U, Blum H, Schnare M, Rollinghoff M, Gessner A. A soluble form of the murine common gamma chain is present at high concentrations in vivo and suppresses cytokine signaling. Blood 2001;97:183-191.
29. Parry CM, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcami A. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 2000;191:573-578.
30. van Berkel V, Barrett J, Tiffany HL, Fremont DH, Murphy PM, McFadden G, Speck SH, Virgin HI. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol 2000; 74:6741-6747.
31. Alcami A, Symons JA, Collins PD, Williams TJ, Smith GL. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 1998;160:624-633.
32. Murayama T, Ohara Y, Obuchi M, Khabar KSA, Higashi H, Mukaida N, Matsushima K. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1 and NF-kappaB-binding sites of the interleukin-8 gene. J Virol 1997;71:5692-5695.
33. Eliopoulos AG, Gallagher NJ, Blake SMS, Dawson CW, Young LS. Activation of the p38 Mitogen-activated Protein Kinase Pathway by Epstein-Barr Virus-encoded Latent Membrane Protein 1 coregulates Interleukin-6 an Interleukin-8 production. J Biol Chem 1999;274:16085-16096.
34. Yamada H, Aihara T, Okabe S. Mechanism for Helicobacter pylori stimulation of interleukin-8 production in a gastric epithelial cell line (MKN 28): roles of mitogen-activated protein kinase and interleukin-1beta. Biochem Pharm 2001;61:1595-1604.
35. Belcher CE, Drenkow J, Kehoe B, Gingeras TR, McNamara N, Lemjabbar H, Basbaum C, Relman DA. The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies. Proc Nat Acad Sci USA 2000;97:13847-13852.
36. Jefferson KK, Smith MF Jr, Bobak DA. Roles of intracellular calcium and NF-kappa B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes. J Immunol 1999;163:5183-5191.
37. Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, Kelly CP. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J Clin Invest 2000;105:1147-1156.
38. Milne RS, Mattick C, Nicholson L, Devarai P, Alcami A, Gompels UA. RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 2000;164:2396-2404.
39. Smith AM, Guzman CA, Walker MJ. The virulence factors of Bordetella pertussis: a matter of control. FEMS Microbiol Rev 2000;25: 309-333.
40. Cooper JA Jr, Ridgeway AL, Pearson J, Culbreth RR. Attenuation of interleukin 8-induced nasal inflammation by an inhibitor peptide. Am J Respir Crit Care Med 2001;163:1198-1205.
41. Cooper JA Jr, Carcelen R, Culbreth R. Effects of Influenza A nucleoprotein on polymorphonuclear neutrophil function. J Injectious Dis 1996; 173:279-284.
42. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 1999;38:12959-12968.
43. Hirose J, Kawashima H, Yoshie O, Tashiro K, Miyasaka M. Versican interacts with chemokines and modulates cellular responses. J Biol Chem 2001;276:5228-5234.
44. Van den Steen PE, Opdenakker G, Wormald MR, Dwek RA, Rudd PM. Matrix remodelling enzymes, the protease cascade and glycosylation. Biochimica Biophysica Acta 2001;1528:61-73.
45. Tsuda H, Yamada S, Miyazono H, Morikawa K, Yoshida K, Goto F, Tamura J, Neumann KW, Ogawa T, Sugahara K. Substrate specificity studies of Flavobacterium chondroitinase C and heparitinases towards the glycosaminoglycan-protein linkage region. Eur J Biochem 1999;262: 127-133.
46. Godavarti R, Davis M, Venkataraman G, Cooney C, Langer R, Sasisekharan R. Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli. Biochem Biophys Res Commun 1996;225:751-758.
47. Su H, Blain F, Musil RA, Zimmermann JJ, Gu K, Bennett DC. Isolation and expression in Escherichia coli of hepB and hepC, genes coding for the glycosaminoglycan-degrading enzymes heparinase II and heparinase III, respectively, from Flavobacterium heparinum. Appl Environ Microbiol 1996;62:2723-2734.
48. Santala A, Saarinen J, Kovanen P, Kuusela P. Activation of interstitial collagenase, MMP-1, by Staphylococcus aureus cells having surface-bound plasmin: a novel role of plasminogen receptors of bacteria. FEBS Lett 1999;461:153-156.
49. Choi BK, Jung JH, Suh HY, Yoo YJ, Cho KS, Chai JK, Kim CK. Activation of matrix metalloproteinase-2 by a novel oral spirochetal species Treponema lecithinolyticum. J Periodontol 2001;72:1594-1600.
50. Price NM, Farrar J, Tran TT, Nguyen TH, Tran TH, Friedland JS. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immun 2001;166:4223-4230.
51. Panagakos FS, O'Boskey JFJ, Rodriguez E. Regulation of pulp cell matrix metalloproteinase production by cytokines and lipopolysaccharides. J Endod 1996;22:358-361.
52. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, Clark-Lewis I, Overall CM. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001;276:43503-43508.
53. McQuibban GA, Gong JH, Tam EM, McCulloch CAG, Clark-Lewis I, Overall CM. Inflammation dampened by Gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000;289:1202-1206.
54. McColl SR, Clark-Lewis I. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J Immunol 1999;163: 2829-2835.
55. Loetscher P, Gong JH, Dewald B, Baggiolini M, Clark-Lewis I. N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities. J Biol Chem 1998;273: 22279-22283.
56. Culley FJ, Brown A, Conroy DM, Sabroe I, Pritchard DI, Williams TJ. Eotaxin is specifically cleaved by hookworm metalloproteases preventing its action in vitro and in vivo. J Immunol 2000;165:6447-6453.
57. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000;96:2673-2681.
58. Johnston JB, Jiang Y, van Marle G, Mayne MB, Ni W, Holden J, McArthur JC, Power C. Lentivirus infection in the brain ilnduces matrix metalloproteinase expression: role of envelope diversity. J Virol 2000;74:7211-7220.
59. Youssef S, Maor G, Wildbaum G, Grabie N, Gour-Lavie A, Karin N. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J Clin Invest 2000;106:361-371.
60. Krakauer T. Immune response to staphylococcal superantigens. Immunol Res 1999;20:163-173.
61. Schiffenbauer J, Soos J, Johnson H. The possible role of bacterial superantigens in the pathogenesis of autoimmune disorders. Immunol Today 1998;19:117-120.
62. Owens T, Babcock A. Immune response induction in the central nervous system. Front Biosci 2002;1:d427-d438.
63. Morse SS, Sakaguchi N, Sakaguchi S. Virus and autoimmunity: induction of autoimmune disease in mice by mouse T lymphotropic virus (MTLV) destroying CD4 + T cells. J Immunol 1999;162:5309-5316.
64. Arkwright PD, Abinun M, Cant AJ. Autoimmunity in human primary immunodeficiency diseases. Blood 2002;99:2694-2702.
65. Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N, Peiper SC. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood 2000;96:1681-1684.
66. Burns JM, Dairaghi DJ, Deitz M, Tsang M, Schall TJ. Comprehensive mapping of poxvirus vCCl chemokine-binding protein. J Biol Chem 2002;277:2785-2789.
67. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 2002;8(6):567-573.
68. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2000;14:1693-1711.
69. Jankovic D, Liu Z, Gause WC. Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol 2001;22:450-457.
70. Sozzani S, et al. The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 1998;92:4036-4039.
71. Endres MJ, Garlisi CG, Xiao H, Shan L, Hedrick JA. The Kaposi's sarcoma-related Herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J Exp Med 1999;189:1993-1998.
72. Mellado M, de Ana AM, Moreno MC, Martinez C, Rodriguez-Frade JM. A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death. Curr Biol 2001;11:691-696.
73. Murayama T, Mukaida N, Khabar KSA, Matsushima K. Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. J Leukocyte Biol 1998;64:62-67.
74. Zou P, Isegawa Y, Haque M, Horiguchi Y, Yamanishi K. Human Herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol 1999;73:5926-5933.
75. Grundy JE, Lawson KM, MacCormac LP, Fletcher JM, Yong KL. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophilendothelial contact and during neutrophil transendothelial migration. J Infect Diseases 1998;177:1465-1474.
76. Mahalingam S, Karupiah G Chemokines and chemokine receptors in infectious diseases. Immunol Cell Biol 1999;77:469-475.
77. Craigen JL, Yong KL, Jordan NJ, MacCormac LP, Westwick J, Akbar AN, Grundy JE. Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology 1997;92:138-145.
78. Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, Liu LY, Lucas A, Clark-Lewis I, Meyer RW, McFadden G. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 1997;229:12-24.
79. Cao JX, Gershon PD, Black DN. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G- protein-coupled chemokine receptor homologue. Virology 1995;209: 207-212.
80. Martin WJ. Chemokine receptor-related genetic sequences in an african green monkey simian cytomegalovirus-derived stealth virus. Exp Mol Pathol 2000;2000:1.
81. Isegawa Y, Ping Z, Nakano K, Sugimoto N, Yamanishi K. Human Herpesvirus 6 open reading frame U12 encodes a functional betachemokine receptor. J Virol 1998;72:6104-6112.
82. Martin WJ. Melanoma growth stimulatory activity (MGSA/GRO-alpha) chemokine genes incorporated into an African green monkey simian cytomegalovirus-derived stealth virus. Exp Mol Pathol 1999;66: 15-18.
83. Fleming P, Davis-Poynter N, Degli-Esposti M, Densley E, Papadimitriou J, Shellam G, Farrell H. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J Virol 1999;73: 6800-6809.
84. Saederup N, Aguirre SA, Sparer TE, Bouley DM, Mocarski ES. Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol 2001;75:9966-9976.